Bahrain
Download data
11 March 2022
Date of search
11 March 2022
Certificate adoption
A certificate is adopted
Instrument type
Vaccination and immunity based
Certificate name
Digital Covid-19 vaccine passport
Certificate details
The certificate contains this following information:
- name
- date of birth
- nationality
- which vaccine they received.
Entry protocol
For general measures
Document requirements
All travellers arriving in the Kingdom of Bahrain aged 6 years and above are required to:
- No need to present a PCR certificate before boarding a plane for travellers arriving in the kingdom of Bahrain.
- Take a PCR test upon arrival.
- Recently recovered travellers (age 6 years and above) are not required to present a negative PCR test before departure. In lieu of a negative PCR test, travellers who have recently recovered from a COVID-19 infection can present documentary proof in the form of a recovery certificate or a positive PCR test taken no later than 14 days prior to departure and no earlier than 30 days prior to departure. Travellers are still required to undergo a PCR test on arrival in Bahrain.
- All travellers must also activate the ‘BeAware Bahrain‘ application and sign an agreement to self–isolate, which requires them to quarantine at their place of residence until their arrival test results are available.
- Citizens planning to travel abroad must comply with entry procedures and requirements at their destinations. They must also sign a declaration form prior to departure, agreeing to bear any medical costs while abroad, as well as mandatory COVID-19 testing once they arrive in the Kingdom of Bahrain.
Quarantine
- All unvaccinated arrivals into Bahrain aged 12 years and above, will be required to self–isolate for 7 days as part of the arrivals testing procedure, unless exempt as set out above.
- Those who test positive for COVID-19 are required to self–isolate at home or at their hotel for 7 days (if fully vaccinated) or 10 days (if unvaccinated) from the date of infection.
Vaccine authorised to be used in the country
- Pfizer/BioNTech
- Sputnik Light
- Sputnik V
- Janssen (Johnson & Johnson)
- Covishield (Oxford/ AstraZeneca formulation)
- Covaxin
- Sinopharm (Beijing)
Border status
Partially open.